Pfizer (PFE) Shares Outstanding (Weighted Average) (2009 - 2026)

Pfizer (PFE) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $5.7 billion in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) changed 0.28% year-over-year to $5.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 billion (changed 0.28% YoY) and the FY2025 annual result came in at $5.7 billion, changed 0.34% from the prior year.
• Shares Outstanding (Weighted Average) was little changed at $5.7 billion in Q1 2026 per PFE's latest filing, from $5.7 billion in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $5.7 billion in Q1 2026 and bottomed at $5.6 billion in Q3 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $5.7 billion (2024), against an average of $5.7 billion.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) advanced 0.12%; it then rose 0.73% in 2023.
• Tracing PFE's Shares Outstanding (Weighted Average) over 5 years: stood at $5.6 billion in 2022, then grew by 0.62% to $5.6 billion in 2023, then gained by 0.37% to $5.7 billion in 2024, then climbed by 0.34% to $5.7 billion in 2025, then rose by 0.14% to $5.7 billion in 2026.
• Per Business Quant, the three latest PFE Shares Outstanding (Weighted Average) figures stand at $5.7 billion (Q1 2026), $5.7 billion (Q4 2025), and $5.7 billion (Q3 2025).

Peer Comparison